TrialLancet (London, England)2017

Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial.

Julia K Prague et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.